A Phase 3 Study of JNS013 in Patients With Chronic Pain.

Trial Profile

A Phase 3 Study of JNS013 in Patients With Chronic Pain.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Sep 2013

At a glance

  • Drugs Tramadol/paracetamol (Primary)
  • Indications Back pain; Musculoskeletal pain
  • Focus Therapeutic Use
  • Sponsors Janssen Pharmaceutical KK
  • Most Recent Events

    • 24 Mar 2012 Results presented at the 2012 IOF World Congress on Osteoporosis and 11th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis.
    • 18 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Apr 2009 Patient number amended from 252 to 321 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top